Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteria.
Fresán D, Luque S, Benítez-Cano A, Sorlí L, Montero MM, De-Antonio M, Vega V, Roberts JA, Horcajada JP, Grau S. Fresán D, et al. Among authors: horcajada jp. J Antimicrob Chemother. 2023 Dec 1;78(12):2810-2815. doi: 10.1093/jac/dkad296. J Antimicrob Chemother. 2023. PMID: 37823445
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence.
Lopez-Montesinos I, Montero MM, Domene-Ochoa S, López-Causapé C, Echeverria D, Sorlí L, Campillo N, Luque S, Padilla E, Prim N, Grau S, Oliver A, Horcajada JP. Lopez-Montesinos I, et al. Among authors: horcajada jp. Antibiotics (Basel). 2022 Oct 22;11(11):1456. doi: 10.3390/antibiotics11111456. Antibiotics (Basel). 2022. PMID: 36358110 Free PMC article.
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review.
Echeverria-Esnal D, Sorli L, Navarrete-Rouco ME, Prim N, Barcelo-Vidal J, Conde-Estévez D, Montero MM, Martin-Ontiyuelo C, Horcajada JP, Grau S. Echeverria-Esnal D, et al. Among authors: horcajada jp. Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):759-775. doi: 10.1080/14787210.2023.2223977. Epub 2023 Jun 14. Expert Rev Anti Infect Ther. 2023. PMID: 37294450 Review.
Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID).
Horcajada JP, Aldonza R, Real M, Castañeda-Espinosa S, Sendra E, Gomez-Junyent J, López-Montesinos I, Gómez-Zorrilla S, Briansó S, Duran-Taberna M, Fernández A, Tarragó C, Auguet-Quintillá T; COVID-MAR Research group; COVID-HJ23 group. Horcajada JP, et al. Pneumonia (Nathan). 2024 Feb 25;16(1):3. doi: 10.1186/s41479-023-00124-6. Pneumonia (Nathan). 2024. PMID: 38402214 Free PMC article.
New Predictive Equation for the Estimation of Plasma Concentrations of Formed Colistin in Patients Treated With Colistimethate Sodium for Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S, Sorlí L, Li J, Fernández-Sala X, Berenguer N, Colominas-González E, Benítez-Cano A, Montero MM, Subirana I, Prim N, García-Paricio R, Horcajada JP, Grau S. Luque S, et al. Among authors: horcajada jp. Ther Drug Monit. 2024 Oct 1;46(5):594-602. doi: 10.1097/FTD.0000000000001216. Epub 2024 Jul 9. Ther Drug Monit. 2024. PMID: 38984536
Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study.
De Antonio-Cuscó M, Sorlí L, Muñoz-Bermúdez R, López-Mula C, Parrilla FJ, Gracia-Arnillas MP, Prim N, Campillo Ambrós N, Horcajada JP, Masclans-Enviz JR, Grau S, Luque S. De Antonio-Cuscó M, et al. Among authors: horcajada jp. J Antimicrob Chemother. 2024 Dec 26:dkae444. doi: 10.1093/jac/dkae444. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39723624
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.
Cercenado E, Rodríguez-Baño J, Alfonso JL, Calbo E, Escosa L, Fernández-Polo A, García-Rodríguez J, Garnacho J, Gil-Navarro MV, Grau S, Gudiol C, Horcajada JP, Larrosa N, Martínez C, Molina J, Nuvials X, Oliver A, Paño-Pardo JR, Pérez-Rodríguez MT, Ramírez P, Rey-Biel P, Vidal P, Retamar-Gentil P. Cercenado E, et al. Among authors: horcajada jp. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr;41(4):238-242. doi: 10.1016/j.eimce.2022.05.013. Epub 2023 Jan 5. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36610836 Review.
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project).
Becerra-Aparicio F, Gómez-Zorrilla S, Hernández-García M, Gijón D, Siverio A, Berbel D, Sánchez-Carrillo C, Cercenado E, Rivera A, de Malet A, Xercavins M, Ruiz de Gopegui E, Canoura-Fernández L, Martínez JA, Seral C, Del Pozo JL, Cotarelo M, Díaz-Regañón J, Cantón R, Oliver A, Horcajada JP, Ruiz-Garbajosa P. Becerra-Aparicio F, et al. Among authors: horcajada jp. J Antimicrob Chemother. 2023 Sep 5;78(9):2291-2296. doi: 10.1093/jac/dkad234. J Antimicrob Chemother. 2023. PMID: 37533351
353 results